Eurobio Scientific Société anonyme's latest marketcap:
As of 08/16/2025, Eurobio Scientific Société anonyme's market capitalization has reached $298.71 M. According to our data, Eurobio Scientific Société anonyme is the 17977th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 298.71 M |
| Revenue (ttm) | 181.24 M |
| Net Income (ttm) | 4.68 M |
| Shares Out | 10.03 M |
| EPS (ttm) | 0.46 |
| Forward PE | 21.94 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/25/2025 |
Eurobio Scientific Société anonyme's yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/16/2025 | €255.38 M | $298.71 M | 0.5% | 17977 |
| 12/31/2024 | €253.6 M | $262.53 M | 50.69% | 17276 |
| 12/29/2023 | €168.29 M | $185.75 M | -23.8% | 19245 |
| 12/30/2022 | €220.86 M | $236.38 M | -24.43% | 17044 |
| 12/31/2021 | €292.27 M | $332.19 M | 52.26% | 15872 |
| 12/31/2020 | €191.95 M | $234.44 M | 275.12% | 15932 |
| 12/31/2019 | €51.17 M | $57.38 M | 68.7% | 21160 |
| 12/31/2018 | €30.33 M | $34.78 M | -33.39% | 22870 |
| 12/29/2017 | €45.54 M | $54.62 M | 82.02% | 21081 |
| 12/30/2016 | €25.02 M | $26.31 M | -25.94% | 22208 |
Company Profile
About Eurobio Scientific Société Anonyme
Eurobio Scientific Société Anonyme specializes in the design, development, and commercialization of in vitro diagnostics products across key medical fields, including:
- Transplantation
- Immunology
- Infectious diseases
- Life sciences
- Cancer research
Key Products & Services
The company offers a diverse portfolio of diagnostic solutions, including:
- Cornea graft solutions – Media for transportation, preservation, and surgical devices.
- AlloMap – A molecular test for monitoring heart-transplant patients.
- Cell culture media & reagents – Including proprietary antibodies and molecular biology reagents.
- TQS (Tetanus Quick Stick) – For assessing immune status against tetanus.
- EBX molecular biology tests – Identifying pathogens and evaluating infection severity.
Innovation & Development
Eurobio Scientific is actively engaged in advancing diagnostic technologies through molecular biology, with a focus on precision medicine and infectious disease detection.
Company Background
Originally founded as Diaxonhit in 1997, the company rebranded to Eurobio Scientific Société Anonyme in June 2018. Headquartered in Les Ulis, France, it continues to expand its diagnostic solutions globally.
Frequently Asked Questions
-
What is Eurobio Scientific Société anonyme's (EPA-ALERS) current market cap?As of 08/16/2025, Eurobio Scientific Société anonyme (including the parent company, if applicable) has an estimated market capitalization of $298.71 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Eurobio Scientific Société anonyme (EPA-ALERS) rank globally by market cap?Eurobio Scientific Société anonyme global market capitalization ranking is approximately 17977 as of 08/16/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.